Search for: "BCS Development LLC"
Results 41 - 48
of 48
Sorted by Relevance
|
Sort by Date
26 May 2013, 5:30 am
The Illusion of More http://t.co/Y7EpYKZQmk -> Grooveshark settlement leaves future in doubt http://t.co/1nApbUiz3r -> Can an LLC member violate the Stored Communications Act by accessing other members’ email? [read post]
29 Aug 2010, 6:31 am
In an article published in the “New Statesman” under the headline “How our libel laws censor scientists” Simon Singh discusses the development of US libel laws in the wake of New York Times v Sullivan, concluding that “We may not want English libel laws that completely mimic the US system in every detail. [read post]
16 Feb 2015, 11:12 am
Here’s what he wrote: The second piece of information Levine seeks is an explanation as to why Seven Pines used a 4.9% capitalization rate in determining the cash merger price in the merger proposal, but the BCS Appraisal, now relied on by Seven Pines, used a 6.75% capitalization rate. [read post]
3 Sep 2012, 3:15 am
KF 6452 F764 2012 Understanding partnership and LLC taxation / Jerold Friedland. [read post]
6 Nov 2018, 4:09 pm
I recently had the honour to be invited to give a guest lecture to the Copyright Society of Australia in Sydney. [read post]
9 Jan 2009, 7:00 am
(IP Think Tank) World Customs Organisation to replace controversial IP standards body; doubts remain (Intellectual Property Watch) Rebalance your IP portfolio for 2009 (IP Spotlight) IAM blog’s IP personalities of 2008 (IAM) Key themes for 2009 – from green patents to the IP marketplace (IAM) Experts examine strategies for IP and sustainable development (Intellectual Property Watch) The paradox of accounting innovation (IP Frontline) Saving your IP (Patent Baristas)… [read post]
28 Jun 2017, 9:26 am
For a summary of the prior proceedings, see Barry Sookman, Google ordered by BC court to block websites: Equustek Solutions Inc. v. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
